ANI Pharmaceuticals in Princeton have announced the retirement of chairman Patrick Walsh, effective after completing his current term on the company’s board of directors.
Thomas Haughey, a member of the board since May 2018, has been elected as the next chairman of the board.
Walsh was grateful for his tenure.
“It has been a privilege to serve as ANI’s Chairman and contribute to its significant growth and success,” he said. “I am immensely proud of the evolution of ANI’s business and am confident in the team’s ability to continue its goals moving forward.”
Haughey will step down as chair of the audit and finance committee as he prepares to take the role as ANI’s chairman of the board . Jeanne Thoma, a member of the Board since 2020, will assume the role of chair of the audit and finance committee. Haughey will continue to serve as a member of the audit and finance committee and as a member of the nominating and corporate governance committee.
ANI President Nikhil Lalwani summarized the transactions.
“For over seven years, Pat has served as a trusted advisor to ANI and a champion of our purpose,” he said. Personally, I am grateful to Pat for his mentorship, guidance and support. On behalf of the Board and the entire ANI team, I want to thank him for his distinguished leadership and contributions to the lives of patients and the creation of shareholder value. We wish him all the best in his retirement.
Likewise, we are delighted to acknowledge Tom’s significant contributions to the Company as a Board member for the past seven years and to welcome him as our next Chairman as we significantly expand our Rare Disease business.”
